Sinohealth Holdings Limited
SEHK:2361 株式レポート
Sinohealth Holdings マネジメント 主要情報 CEO給与比率 65.0% CEO在任期間 5.7yrs CEOの所有権 44.3% 経営陣の平均在職期間 データなし 取締役会の平均在任期間 3yrs
経営陣の近況
Sinohealth Holdings Limited Announces Resignation of Wan Chuan as Joint Company Secretary Sep 10
Sinohealth Holdings Limited, Annual General Meeting, Jun 19, 2024 Mar 30 Sinohealth Holdings Limited, Annual General Meeting, Jun 19, 2024
High number of new and inexperienced directors Nov 16
Insufficient new directors Jul 12
すべての更新を表示
Sinohealth Holdings' (HKG:2361) Anemic Earnings Might Be Worse Than You Think Sep 30
Sinohealth Holdings Limited Announces Resignation of Wan Chuan as Joint Company Secretary Sep 10
First half 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.11 in 1H 2023) Sep 02
Consensus EPS estimates fall by 14% Aug 29
Sinohealth Holdings Limited to Report First Half, 2024 Results on Aug 28, 2024 Aug 16
Sinohealth Holdings Limited Declares Final Dividend for the Year Ended December 31, 2023 Jun 19
Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Apr 27
Sinohealth Holdings Limited, Annual General Meeting, Jun 19, 2024 Mar 30 Sinohealth Holdings Limited, Annual General Meeting, Jun 19, 2024
Sinohealth Holdings Limited to Report Fiscal Year 2023 Results on Mar 28, 2024 Mar 19
Investor sentiment improves as stock rises 19% Dec 26
Consensus revenue estimates decrease by 11%, EPS upgraded Sep 01
First half 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.01 in 1H 2022) Aug 28
New major risk - Revenue and earnings growth Aug 26
Sinohealth Holdings Limited to Report Q2, 2023 Results on Aug 25, 2023 Aug 16
Investor sentiment improves as stock rises 21% Jun 30
Sinohealth Holdings Limited Declares Final Dividend for the Year Ended 31 December 2022 Jun 20
Weak Statutory Earnings May Not Tell The Whole Story For Sinohealth Holdings (HKG:2361) Apr 28
Investor sentiment improves as stock rises 16% Apr 28
Sinohealth Holdings Limited Just Recorded A 240% EPS Beat: Here's What Analysts Are Forecasting Next Apr 02
Full year 2022 earnings: EPS and revenues exceed analyst expectations Mar 31
Investor sentiment improves as stock rises 16% Feb 27
Investor sentiment improved over the past week Dec 06
Investor sentiment deteriorated over the past week Nov 21
High number of new and inexperienced directors Nov 16
Investor sentiment deteriorated over the past week Oct 28
Investor sentiment improved over the past week Sep 23
First half 2022 earnings released Sep 03
Investor sentiment deteriorated over the past week Aug 31
Sinohealth Holdings Limited to Report First Half, 2022 Results on Aug 29, 2022 Aug 18
Sinohealth Holdings Limited has completed an IPO in the amount of HKD 402 million. Jul 12
Insufficient new directors Jul 12
CEO報酬分析 Sinohealth Holdings の収益と比較して、Yushu Wu の報酬はどのように変化したか？ 日付 総報酬 給与 会社業績 Jun 30 2024 n/a n/a CN¥96m
Mar 31 2024 n/a n/a CN¥99m
Dec 31 2023 CN¥1m CN¥657k CN¥102m
Sep 30 2023 n/a n/a CN¥101m
Jun 30 2023 n/a n/a CN¥100m
Mar 31 2023 n/a n/a CN¥78m
Dec 31 2022 CN¥940k n/a CN¥56m
Sep 30 2022 n/a n/a CN¥61m
Jun 30 2022 n/a n/a CN¥66m
Mar 31 2022 n/a n/a CN¥72m
Dec 31 2021 CN¥708k CN¥652k CN¥79m
Dec 31 2020 CN¥810k CN¥671k CN¥68m
Dec 31 2019 CN¥685k CN¥592k CN¥56m
報酬と市場: Yushuの 総報酬 ($USD 140.24K ) は、 Hong Kong市場 ($USD 348.79K ) の同様の規模の企業の平均を下回っています。
報酬と収益: Yushuの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者 Mr. Yushu Wu (also known as Wu Han) is the founder of Sinohealth Group. He is the Chairman of the Board and Chief Executive Officer of Sinohealth Holdings Limited. He was appointed as a director of Sinohea ... Show more
取締役 名称 ポジション 在職期間 報酬 所有権 Chairman & CEO 5.7yrs CN¥1.01m 44.3% HK$ 824.6m COO & Executive Director 3.4yrs CN¥1.01m 4.95% HK$ 92.1m Independent Non-Executive Director 2.6yrs CN¥96.00k データなし Independent Non-Executive Director 2.6yrs CN¥96.00k データなし Non-Executive Director 3.4yrs データなし データなし Independent Non-Executive Director 2.6yrs CN¥96.00k データなし
もっと見る
経験豊富なボード: 2361の 取締役会 は 経験豊富 であると考えられます ( 3年の平均在任期間)。
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
